Sandoz Group AG | WebDisclosure

Basculer en Français

11230	Companies
249094	Keywords
177020	Articles
134928	Press releases

Home
Companies
Sandoz Group AG

PRESS RELEASE

published on 01/14/2026 at 12:00, 9 months 12 days ago

Sandoz confirms European Commission approval of Ondibta® (insulin glargine), strengthening overall biosimilars leadership and position in diabetes
Sandoz confirms European Commission approval of Ondibta® (insulin glargine), strengthening overall biosimilars leadership and position in diabetes. Expected launch by early 2027

Diabetes European Commission Biosimilars Sandoz Ondibta
BRIEF

published on 01/12/2026 at 15:05, 9 months 14 days ago

Sandoz Unveils Strategy for 'Golden Decade' of Affordable Medicines

Market Strategy Biosimilars Sandoz Group AG Golden Decade Affordable Medicines
BRIEF

published on 01/12/2026 at 15:05, 9 months 14 days ago

Sandoz dévoile sa stratégie pour une « décennie d'or » des médicaments abordables

Stratégie De Marché Biosimilaires Groupe Sandoz AG Médicaments Abordables Décennie Dorée
PRESS RELEASE

published on 01/12/2026 at 15:00, 9 months 14 days ago

Sandoz CEO, speaking at 44th Annual J.P. Morgan Healthcare Conference, will outline plans to capitalize on unprecedented ’golden decade’ of affordable medicines opportunity
Sandoz CEO to outline plans for capturing the unprecedented 'golden decade' of affordable medicines opportunity at the 44th Annual J.P. Morgan Healthcare Conference

CEO Sandoz J.P. Morgan Healthcare Conference Golden Decade Affordable Medicines
BRIEF

published on 12/08/2025 at 07:05, 10 months 18 days ago

Sandoz Acquires Just-Evotec Biologics EU SAS to Boost Biosimilar Leadership

Acquisition Healthcare Biosimilars Sandoz Group AG Continuous Manufacturing
BRIEF

published on 12/08/2025 at 07:05, 10 months 18 days ago

Sandoz acquiert Just-Evotec Biologics EU SAS pour renforcer son leadership dans le domaine des biosimilaires

Acquisition Soins De Santé Biosimilaires Groupe Sandoz AG Fabrication Continue
PRESS RELEASE

published on 12/08/2025 at 07:00, 10 months 18 days ago

Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership
Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership. Expands capabilities for biosimilars with cutting-edge technology

Acquisition Biosimilars Sandoz Just-Evotec Biologics EU SAS Continuous-manufacturing Technology
BRIEF

published on 12/01/2025 at 07:05, 10 months 25 days ago

Sandoz Launches Denosumab Biosimilars in Europe

Bone Health Sandoz Denosumab Biosimilars Wyost® Jubbonti®
BRIEF

published on 12/01/2025 at 07:05, 10 months 25 days ago

Sandoz lance des biosimilaires de dénosumab en Europe

Sandoz Wyost® Jubbonti® Biosimilaires Du Dénosumab Santé Osseuse
PRESS RELEASE

published on 12/01/2025 at 07:00, 10 months 25 days ago

Sandoz launches denosumab biosimilars in Europe, providing affordable treatment option for cancer-related bone disease and osteoporosis for millions of patients
Sandoz launches denosumab biosimilars in Europe, providing affordable treatment options for cancer-related bone disease and osteoporosis. The European launch marks a key milestone in Sandoz's growth strategy

Europe Biosimilars Cancer Osteoporosis Sandoz

Accesswire

Published on 10/26/2026 at 23:00, 33 minutes ago

American Hotel Income Properties REIT LP to Host Third Quarter 2026 Results Conference Call on November 16, 2026
Published on 10/26/2026 at 22:00, 1 hour 33 minutes ago

IBC Advanced Alloys Announces Issuance of Share-Based Compensation to Directors
Published on 10/26/2026 at 22:00, 1 hour 33 minutes ago

Alset AI Announces Non-Brokered Private Placement Offering of a Minimum of $650,000 and a Maximum of $800,000
Published on 10/26/2026 at 21:30, 2 hours 3 minutes ago

Clean Air Metals Announces Auditor Review of Q2 Financial Statements
Published on 10/26/2026 at 14:10, 9 hours 23 minutes ago

China XLX Announces 2026 9M Results

View all ACCESSWIRE

EQS Group

Published on 10/26/2026 at 22:23, 1 hour 10 minutes ago

EQS-Adhoc: SMAG Mobile Antenna Masts AG: Changes to the Management Board
Published on 10/26/2026 at 21:57, 1 hour 35 minutes ago

EQS-Adhoc: PAUL Tech AG: Noteholders’ Meeting in respect of the EUR 35 million notes resolves on extension of the term of the notes
Published on 10/26/2026 at 21:32, 2 hours ago

UPDATE ON STRATEGIC TRANSACTION, FURTHER PORTFOLIO DISPOSAL PROCESS AND CONTINUED LENDER SUPPORT
Published on 10/26/2026 at 20:00, 3 hours 32 minutes ago

EQS-Adhoc: Hypoport SE: Gross profit growth and increase in EBIT in Q1-Q3 2026
Published on 10/26/2026 at 19:10, 4 hours 23 minutes ago

PolyPeptide announces results of the extraordinary general meeting of shareholders

Les Echos

Published on 10/26/2026 at 18:11, 5 hours 22 minutes ago

Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 18:11, 5 hours 22 minutes ago

Déclaration des transactions sur actions propres réalisées du 19/10/2026 au 25/10/2026
Published on 10/26/2026 at 17:45, 5 hours 48 minutes ago

Weekly share buyback
Published on 10/26/2026 at 17:45, 5 hours 48 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 10/26/2026 at 17:45, 5 hours 48 minutes ago

Infotel : Déclaration des transactions sur actions propres réalisées du 19 au 23 octobre 2026 dans le cadre du programme de rachat d’actions.

View all LES ECHOS COMFI WIRE